Results for tag: "Bone Resorption Drug"

The Bone Resorption Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. These drugs are used to treat conditions such as osteoporosis, Paget's disease, and hypercalcemia. They work by reducing the activity of osteoclasts, the cells responsible for breaking down bone. This helps to reduce bone loss and improve bone density. Commonly used drugs in this market include bisphosphonates, calcitonin, and denosumab. The Bone Resorption Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in this market include Amgen, Merck, Novartis, Pfizer, and Sanofi. Other companies such as Eli Lilly, GlaxoSmithKline, and Teva Pharmaceuticals also have a presence in this market. Show Less Read more